Madrigal poised to enter European MASH market after CHMP endorsement
Revenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.
Revenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.
What's Your Reaction?
